[Safety of antimalarial drugs administered at prophylactic doses during pregnancy].
Aguilera
C
C
Servei de Farmacologia Clínica, Fundació Institut Català de Farmacologia, Hospitals Vall d'Hebron, Barcelona.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage* / Q000009:adverse effects / Q000633:toxicity; D002986:Clinical Trials as Topic; D016001:Confidence Intervals; D005260:Female; D005313:Fetal Death / Q000139:chemically induced; D005333:Fetus / Q000187:drug effects; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D008288:Malaria / Q000517:prevention & control*; D016017:Odds Ratio; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000517:prevention & control*; D012189:Retrospective Studies; D012449:Safety; D013997:Time Factors
D000962:Antimalarials